Product & Brand Strategy

At Evaluate, our mission is simple: to help patients gain access to life-saving therapies. Evaluate is a Norstella company, a collection of prominent pharmaceutical solutions providers that have joined forces to offer a full range of consultancy services and solutions. Evaluate provides life sciences clients with the right tools and expertise to navigate complexities at each step of the drug development life cycle, from pipeline to patient. Our offerings include cutting-edge data solutions, consensus forecasts and expert advisory services alongside advanced technologies such as machine learning and predictive analytics.

The Product & Brand Strategy data product provides a comprehensive view of product sales, patent landscapes, clinical trial progress, and more. This data product empowers users to deliberate planning and execution of initiatives to position and promote pharmaceutical products effectively in the market.

The following sets of data have been included in this listing:

Drugs - Names and Identifiers: This table provides a list of drugs along with their unique identifiers. It can be used to cross-reference drugs across different tables and databases.

Drugs - Classifications: This table categorizes drugs based on their therapeutic class, mechanism of action, and other criteria. It can be used to identify potential competitors or to find drugs with similar mechanisms of action.

Drugs - Product Sales: This table provides sales data for different drugs. It can be used to assess the market performance of a drug and compare it with others in the same therapeutic class.

Drugs - Patents & IP: This table provides information about the intellectual property associated with each drug, including patent expiration dates. It can be used to assess the competitive landscape and identify opportunities for generic entry.

Drugs - Sales by Indication (WW and US): This table provides sales data for drugs broken down by indication. It can be used to identify lucrative indications or assess the performance of a drug in different indications.

Companies - Names and Identifiers: This table provides a list of pharmaceutical companies along with their unique identifiers. It can be used to cross-reference companies across different tables and databases.

Drugs - USA - Medicare Part D: This table provides information about the coverage of different drugs under Medicare Part D in the USA. It can be used to assess market access and reimbursement scenarios.

Clinical trials - Dates: This table provides information about the dates of different stages of clinical trials for each drug. It can be used to track the progress of a drug through the development pipeline.

Once you subscribe to this listing, you will have access to all the data tables required.

Workflow:

• Consumer clicks Request button on Evaluate listing<br/>• Evaluate will reach out to the consumer and finalize terms.<br/>• Evaluate shares the data product with the consumer via Snowflake shares.

Additional Information<br/>This data product is updated regularly to ensure that you have the most recent and accurate information. If you have any questions or need further information, please don’t hesitate to contact us.

搜集汇总

背景与挑战

背景概述

该数据集由Evaluate公司提供，专注于产品与品牌战略，涵盖药物销售、专利、临床试验进展等多维度信息，旨在支持用户进行药物市场定位与推广的规划与执行。数据集包含多个数据表，如药物标识、分类、销售数据及临床试验日期，可帮助评估市场表现和竞争格局。